Yoshua Bengio becomes scientific advisor of Perceiv AI - Mila

Yoshua Bengio, Founder of Mila and computer science professor at University of Montreal, will support the ongoing research of Perceiv AI in precision medicine to improve and optimize drug development clinical trials. Founded by graduate students out of University of Montreal and Mila, Perceiv AI aims to improve treatment efficacy thanks to refined patient selection. Through advanced Machine Learning algorithms, Perceiv AI helps pharmaceutical companies with more efficient and accurate subject stratification for their clinical trials. Heterogeneity in patient populations creates challenges in enrolment for clinical trials, which can result in increased trial costs and failures, delaying the commercialization of much-needed treatments. "For having seen the ravages of diseases like Alzheimer's from up close, I am very motivated to see more development of AI techniques, such as done at Perceiv AI, to provide better targeted treatments, and I am delighted to see the next generation of AI researchers embarking on such projects of important value for society while contributing to grow the startup ecosystem in Montreal," said Yoshua Bengio, Ph.D. "We are thrilled to reinforce our relationship with Mila and to welcome Yoshua as an advisor!" said Christian Dansereau, Ph.D., CEO and co-founder of Perceiv AI. "With their help, we will be able to leverage the most recent advances in Representation Learning to further refine our prognostic biomarkers, not only for Alzheimer's but also for new therapeutic areas."